Vaccine breakthrough hypoxemic COVID-19 pneumonia in patients with auto-Abs neutralizing type I IFNs by Bastard, P, Vazquez, SE, Liu, J, Laurie, MT, Wang, CY, Gervais, A, Le Voyer, T, Le Voyer, T, Bizien, L, Zamecnik, C, Philippot, Q, Rosain, J, Catherinot, E, Willmore, A, Mitchell, AM, Bair, R, Garçon, P, Kenney, H, Fekkar, A, Salagianni, M, Poulakou, G, Siouti, E, Sahanic, S, Tancevski, I, Weiss, G, Nagl, L, Manry, J, Duvlis, S, Arroyo-Sánchez, D, Paz Artal, E, Rubio, L, Perani, C, Bezzi, M, Sottini, A, Quaresima, V, Roussel, L, Vinh, DC, Reyes, LF, Garzaro, M, Hatipoglu, N, Boutboul, D, Tandjaoui-Lambiotte, Y, Borghesi, A, Aliberti, A, Cassaniti, I, Venet, F, Monneret, G, Halwani, R, Sharif-Askari, NS, Danielson, J, Constantinescu, S